About the Authors
- Madlen Loebel
-
Affiliation Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany
- Maren Eckey
-
Affiliation JPT Peptide Technologies GmbH, Berlin, Germany
- Franziska Sotzny
-
Affiliation Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany
- Elisabeth Hahn
-
Affiliation Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany
- Sandra Bauer
-
Affiliation Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany
- Patricia Grabowski
-
Affiliation Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany
- Johannes Zerweck
-
Affiliation JPT Peptide Technologies GmbH, Berlin, Germany
- Pavlo Holenya
-
Affiliation JPT Peptide Technologies GmbH, Berlin, Germany
- Leif G. Hanitsch
-
Affiliation Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany
- Kirsten Wittke
-
Affiliation Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany
- Peter Borchmann
-
Affiliation Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany and German Hodgkin Study Group (GHSG), Cologne, Germany
- Jens-Ulrich Rüffer
-
Affiliation German Fatigue Society e.V. (DFaG), Cologne, Germany
- Falk Hiepe
-
Affiliation Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany
- Klemens Ruprecht
-
Affiliation Department of Neurology and Clinical and Experimental Multiple Sclerosis Research Center, Charité University Medicine Berlin, Berlin, Germany
- Uta Behrends
-
Affiliations Children’s Hospital Schwabing, Technische Universität München (TUM), Munich, Germany, Department of Gene Vectors, Helmholtz Center Munich (HMGU), Munich, Germany, German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
- Carola Meindl
-
Affiliations Children’s Hospital Schwabing, Technische Universität München (TUM), Munich, Germany, Department of Gene Vectors, Helmholtz Center Munich (HMGU), Munich, Germany
- Hans-Dieter Volk
-
Affiliations Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany, Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité University Medicine Berlin, Berlin, Germany
- Ulf Reimer
-
Affiliation JPT Peptide Technologies GmbH, Berlin, Germany
- Carmen Scheibenbogen
-
* E-mail: carmen.scheibenbogen@charite.de
Affiliations Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany, Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité University Medicine Berlin, Berlin, Germany
Competing Interests
Maren Eckey, Johannes Zerweck, Pavlo Holenya and Ulf Reimer are employed by JPT Peptide Technologies GmbH. The commercial affiliation (JPT Peptide Technologies GmbH) does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: CS. Data curation: UR ML. Formal analysis: ML ME PG UR UB CS. Funding acquisition: UR CS. Investigation: ML ME EH SB PG JZ PH LGH KW CM FS. Methodology: ML ME EH SB PG JZ PH LGH KW CM UR CS. Project administration: UR CS. Resources: PB JUR FH KR HDV UB UR CS. Supervision: UR CS. Visualization: ML EH SB FS. Writing – original draft: ML CS. Writing – review & editing: ME UR LGH KW PG JZ PH UB KR FS.